PMID- 12787315 OWN - NLM STAT- MEDLINE DCOM- 20040316 LR - 20190916 IS - 1320-5463 (Print) IS - 1320-5463 (Linking) VI - 53 IP - 6 DP - 2003 Jun TI - Intra-epithelial neuroendocrine carcinoma of the nasal cavity. PG - 396-400 AB - We describe a distinctive neuroendocrine carcinoma (NEC) that proliferated intra-epithelially. The tumor was 35 mm in diameter and arose from the right superior turbinate of a 46-year-old woman. Histologically, the tumor exhibited papillary growth and the tumor cells were localized in the thickened mucosal epithelium. The tumor cells had round to oval and vesicular or hyperchromatic nuclei, and cohered without any specific structure such as a fibrillary background, rosette or glandular structure. No stromal invasion by the tumor was observed. Immunohistochemically, the tumor cells were positive for neuron-specific enolase focally. In addition, many tumor cells expressed cytokeratin (AE1/AE3 and CAM 5.2), mostly with characteristic perinuclear dot-like patterns. Electron microscopy revealed focal but well-eveloped cytoplasmic processes containing arrays of microtubules and a few dense core granules. The tumor was considered to be a poorly differentiated neuroendocrine carcinomas (NEC) that exhibited exceptional intra-epithelial proliferation. The tumor completely disappeared after the stereotactic radiosurgery and has not recurred for 40 months. It might be difficult to distinguish a poorly differentiated NEC in the sinonasal region from other neuroectodermal tumors, including olfactory neuroblastoma, but the differential diagnosis is important because each tumor has different clinicopathological characteristics. FAU - Watanabe, Kazuo AU - Watanabe K AD - Pathology Division, Fukushima Medical University School of Medicine Hospital, Fukushima, Japan. w-kazuo@fmu.ac.jp FAU - Ogura, Go AU - Ogura G FAU - Suzuki, Toshimitsu AU - Suzuki T LA - eng PT - Case Reports PT - Journal Article PL - Australia TA - Pathol Int JT - Pathology international JID - 9431380 RN - 0 (Biomarkers, Tumor) RN - 68238-35-7 (Keratins) RN - EC 4.2.1.11 (Phosphopyruvate Hydratase) SB - IM MH - Biomarkers, Tumor MH - Carcinoma, Neuroendocrine/metabolism/*pathology/surgery MH - Cytoplasmic Structures/ultrastructure MH - Female MH - Humans MH - Immunohistochemistry MH - Keratins/metabolism MH - Magnetic Resonance Imaging MH - Middle Aged MH - Nasal Cavity/*pathology MH - Nose Neoplasms/metabolism/*pathology/surgery MH - Phosphopyruvate Hydratase/metabolism MH - Radiosurgery MH - Treatment Outcome EDAT- 2003/06/06 05:00 MHDA- 2004/03/17 05:00 CRDT- 2003/06/06 05:00 PHST- 2003/06/06 05:00 [pubmed] PHST- 2004/03/17 05:00 [medline] PHST- 2003/06/06 05:00 [entrez] AID - 1487 [pii] AID - 10.1046/j.1440-1827.2003.01487.x [doi] PST - ppublish SO - Pathol Int. 2003 Jun;53(6):396-400. doi: 10.1046/j.1440-1827.2003.01487.x.